Nano Silver Fluoride vs. Silver Diamine Fluoride for Kids’ Cavities
Official title: A Randomized Controlled Trial to Evaluate the Cariostatic Efficacy of Nano Silver Fluoride (NSF) vs. Silver Diamine Fluoride (SDF) in Children
Run by A.T. Still University of Health Sciences · NCT07861321 · Data updated 2026-11-12
This study tests whether Nano Silver Fluoride can stop decay in children as well as Silver Diamine Fluoride.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 6 Years to 10 Years |
| Sex | All |
| Enrollment | 72 (estimated) |
| Sponsor | A.T. Still University of Health Sciences Academic / other |
| Locations | 1 site (Mesa, Arizona) |
| Status | Recruiting |
| Started | October 1, 2026 |
| Main results expected | October 31, 2027 |
| Study ends | October 31, 2030 |
| Registry record updated | October 19, 2026 |
| Trial ID | NCT07861321 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are healthy children aged 6–10 with moderate to advanced caries on at least one deciduous molar and one permanent molar who can consent/assent and attend all visits.
✕Probably not a fit
Some children may not experience a caries arrest benefit or may have adverse reactions to fluoride or silver compounds.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a six-month, double-blind, parallel-group randomized trial conducted at ASDOH in Mesa, AZ. Children aged 6–10 with active caries on at least one primary molar and one permanent molar will receive Nano Silver Fluoride or Silver Diamine Fluoride to see which treatment better arrests caries and how accepted and safe each product is. The study compares cariostatic efficacy and also collects feedback from children, parents, and clinicians on aesthetics and usability. It is designed as a non-inferiority trial, focusing on whether NSF is not worse than SDF in arresting lesions while monitoring safety and tolerability.
Why it matters
Potential benefit: If successful, NSF could provide an effective alternative to SDF for pediatric caries with similar arrest rates and potentially different esthetic or safety profiles.
How similar studies have gone: Prior research has explored silver- and nano-based caries treatments, with mixed results, making this non-inferiority trial among the first direct pediatric comparisons for NSF and SDF.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria * Are between the ages of 6 to 10 years. * Are medically healthy. * Have a minimum of one permanent deciduous molar tooth and one permanent first molar with an occlusal and/or proximal carious lesion classified as ICDAS II (International Caries Detection and Assessment System) Stage 3-4 (moderate caries) or Stage 5-6 (advanced caries). * Must be able to understand and be willing to provide written child assent and parent/guardian consent for study participation. * Must be willing and able to attend all study visits. * Must be able to read and understand English and/or Spanish. * Must be willing to provide feedback about study outcomes in their child (patient-reported/parent-reported outcome measures). Exclusion Criteria * Have a known sensitivity/allergy to fluoride, silver or other heavy-metal ions. * Have a significant medical history, such as cardiac conditions that require antibiotic prophylaxis prior to dental treatment, or poorly controlled/uncontrolled diabetes. * Present with ulcerative gingivitis or aphthous stomatitis. * Have a history of full mouth gingivectomy. * Chronically take medications that reduce salivary flow, including stimulants for ADHD and antihistamines for seasonal allergies. * Have a history of systemic disease that reduces salivary flow, such as an autoimmune disease. * Deciduous molars are loose at the initial screening examination visit. * Deciduous molars or first permanent molars with occlusal and/or proximal caries have an existing restoration or recurrent caries at the site of potential study treatment. * Deciduous molars or first permanent molars have extensive occlusal and/or proximal caries with pulpal involvement and/or require surgical intervention for treatment.
Where it's running
-
Arizona School of Dentistry & Oral Health (ASDOH), A.T. Still University
Mesa, Arizona, United States Recruiting
Study contacts
- Study coordinator: Marc Shlossman Associate Director of Clinical Research, DDS, MS
- Email: mshlossman@atsu.edu
- Phone: (480) 248-8151
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Silver Diamine Fluoride for Caries in Baby Teeth in Routine Dental Care
This study tests whether applying 38% silver diamine fluoride in everyday dental practice can stop decay in primary teeth of children 14 and younger.
-
Digital Caries Risk Questionnaire: does it match CAMBRA in Egyptian adults
A digital self‑administered caries risk questionnaire is being tested to see how well it matches the CAMBRA risk assessment in Egyptian adults who visit the dentist.
-
First permanent molars restored with Cention N in children
This trial tests whether restoring both first permanent molars with Cention N in children aged 8-10 is beneficial for clinical results, x-ray findings, and daily oral health quality of life over 12 months.
-
Ozone therapy to boost remineralization of early caries in kids
This study tests whether adding ozone therapy to a remineralizing gel helps children aged 6–12 remineralize early, non-cavitated caries lesions better than the gel alone.
-
Dental health in children with specific learning disabilities
This study will test the dental caries and oral hygiene of 7–12 year-olds with specific learning disabilities and compare them with healthy peers.
-
Effect of fluoride varnish and chlorhexidine on saliva biomarkers in children with and without active caries
The study tests whether salivary IL-6 and matrix metalloproteinases change after fluoride varnish alone or fluoride varnish with chlorhexidine in kids with active caries compared with caries-free children.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.